We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: heart failure
MedXY News
EnglishTag

heart failure

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Heart Failure Isn’t Scary — Ignoring Early Signs Is: Prevention for 6 High-Risk Groups
Cardiologyearly symptomsheart failure

Heart Failure Isn’t Scary — Ignoring Early Signs Is: Prevention for 6 High-Risk Groups

By MedXY|Oct 5, 2025

Heart failure is a serious but manageable condition. Recognizing early symptoms and understanding risk factors can save lives. Here’s a comprehensive guide on prevention, diagnosis, and management for both the public and health professional

Diuretic-Sparing Potential of Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from FINEARTS-HF
Cardiologyfinerenone
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
heart failure

Diuretic-Sparing Potential of Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from FINEARTS-HF

By MedXY|Oct 4, 2025

Finerenone consistently reduces heart failure events and allows reduction of loop diuretic dosages without impacting new loop diuretic initiation, demonstrating a diuretic-sparing effect in HFmrEF/HFpEF patients.

Unraveling Molecular Links Between Chronic Kidney Disease and Heart Failure via the Plasma Proteome
Cardiologybiomarkerschronic kidney disease

Unraveling Molecular Links Between Chronic Kidney Disease and Heart Failure via the Plasma Proteome

By MedXY|Oct 3, 2025

A comprehensive proteomic analysis from the ARIC study identifies plasma proteins linking kidney dysfunction to incident heart failure, highlighting potential biomarkers and therapeutic targets for HF prevention in CKD patients.

Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction
Cardiologyclinical researchheart failure

Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction

By MedXY|Oct 3, 2025

This study explores the Left Atrial Coupling Index as a key predictor in heart failure patients with preserved ejection fraction.

Risks and Realities of Withdrawing Heart Failure Medications After Ejection Fraction Improvement
CardiologyCardiovascular Mortalityejection fraction

Risks and Realities of Withdrawing Heart Failure Medications After Ejection Fraction Improvement

By MedXY|Oct 3, 2025

Withdrawal of renin-angiotensin inhibitors and mineralocorticoid receptor antagonists in patients with heart failure and improved ejection fraction significantly increases 1-year cardiovascular mortality and hospitalization risks; beta-bloc

Optimizing Blood Transfusion Strategies in Acute Myocardial Infarction with Anemia and Heart Failure: Insights from the MINT Trial
Anesthesiologyanemiablood transfusion

Optimizing Blood Transfusion Strategies in Acute Myocardial Infarction with Anemia and Heart Failure: Insights from the MINT Trial

By MedXY|Oct 3, 2025

The MINT trial reveals that liberal transfusion strategies in MI patients with anemia, including those with heart failure, reduce adverse outcomes compared to restrictive transfusion, supporting a tailored approach to transfusion management

Decade-Long Insights into Deferred Versus Immediate Stenting in STEMI Patients: DANAMI-3-DEFER Trial Findings
Cardiologyheart failurePercutaneous Coronary Intervention

Decade-Long Insights into Deferred Versus Immediate Stenting in STEMI Patients: DANAMI-3-DEFER Trial Findings

By MedXY|Oct 3, 2025

The 10-year DANAMI-3-DEFER study compared deferred stenting to immediate stenting in STEMI, showing no mortality benefit but reduced heart failure hospitalizations with deferred stenting.

Advancements in Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: Insights from the TRILUMINATE Pivotal Trial
Cardiologyheart failureTEER

Advancements in Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: Insights from the TRILUMINATE Pivotal Trial

By MedXY|Oct 3, 2025

Transcatheter edge-to-edge repair (TEER) offers a safe, effective option to reduce tricuspid regurgitation severity, improve quality of life, and lower heart failure hospitalizations up to two years, including in patients with cardiac impla

Pregnancies Following Peri-Partum Cardiomyopathy: Insights from the ESC EuroObservational Research Programme
Cardiologyheart failurematernal outcomes

Pregnancies Following Peri-Partum Cardiomyopathy: Insights from the ESC EuroObservational Research Programme

By MedXY|Oct 3, 2025

This study analyses maternal and neonatal outcomes in subsequent pregnancies after peri-partum cardiomyopathy (PPCM), revealing lower than expected maternal risks and suggesting potential reclassification of pregnancy risk categories based

Leveraging AI-Driven Care to Significantly Reduce Heart Failure Readmissions: The Linea Model
AIartificial intelligenceCare coordination

Leveraging AI-Driven Care to Significantly Reduce Heart Failure Readmissions: The Linea Model

By MedXY|Oct 3, 2025

Linea integrates generative AI and high-touch virtual nursing to proactively manage heart failure patients, achieving a 50% reduction in hospital readmissions within 90 days, substantially lowering costs and improving patient outcomes.

Anaemia as a Predictor of Iron Dysregulation and Modulator of Empagliflozin Response in Heart Failure with Reduced Ejection Fraction: Insights from the EMPATROPISM-FE Trial
Cardiologyempagliflozinheart failure

Anaemia as a Predictor of Iron Dysregulation and Modulator of Empagliflozin Response in Heart Failure with Reduced Ejection Fraction: Insights from the EMPATROPISM-FE Trial

By MedXY|Oct 3, 2025

In patients with heart failure and reduced ejection fraction, anaemia predicts iron homeostasis disruption and influences response to empagliflozin, which increases myocardial iron and improves cardiac function and exercise capacity.

Impact of Structural Cardiac Abnormalities on the Efficacy and Safety of Sacubitril/Valsartan in Patients with Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure: Insights from the PARAGLIDE-HF Trial
Cardiologyheart failureleft ventricular hypertrophy

Impact of Structural Cardiac Abnormalities on the Efficacy and Safety of Sacubitril/Valsartan in Patients with Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure: Insights from the PARAGLIDE-HF Trial

By MedXY|Oct 2, 2025

The PARAGLIDE-HF trial demonstrates that sacubitril/valsartan significantly reduces NT-proBNP in patients with LVEF >40% and worsening heart failure, regardless of left ventricular hypertrophy or left atrial enlargement, but patients wit

Enhancing Muscle Microvascular Function in Heart Failure: The Role of Acute BH4 Administration
Cardiologyheart failureNitric Oxide

Enhancing Muscle Microvascular Function in Heart Failure: The Role of Acute BH4 Administration

By MedXY|Oct 2, 2025

Acute tetrahydrobiopterin (BH4) administration improves locomotor muscle microvascular function in heart failure patients, highlighting the nitric oxide pathway as a promising therapeutic target, while acute antioxidant therapy showed no be

Examining the Link Between Obesity and Kidney Outcomes in Heart Failure with Preserved Ejection Fraction
Cardiologyheart failureHFpEF

Examining the Link Between Obesity and Kidney Outcomes in Heart Failure with Preserved Ejection Fraction

By MedXY|Oct 2, 2025

A pooled analysis of four heart failure trials explores the relationship between obesity and kidney outcomes, revealing waist circumference and waist-to-height ratio as key risk factors, while body mass index showed no significant associati

Evaluating Erythrocytosis Incidence and Thromboembolic Risk in HFrEF Patients Treated with SGLT2 Inhibitors
Cardiologyerythrocytosisheart failure

Evaluating Erythrocytosis Incidence and Thromboembolic Risk in HFrEF Patients Treated with SGLT2 Inhibitors

By MedXY|Oct 2, 2025

This article explores the incidence of erythrocytosis and thromboembolic risk in heart failure patients treated with SGLT2 inhibitors, revealing a higher incidence of erythrocytosis but no associated increase in thromboembolic events over o

Dapagliflozin and Spironolactone: A Promising Combination for Heart Failure with Preserved Ejection Fraction
Cardiologyclinical trialheart failure

Dapagliflozin and Spironolactone: A Promising Combination for Heart Failure with Preserved Ejection Fraction

By MedXY|Oct 2, 2025

The SOGALDI-PEF trial evaluates the effects of dapagliflozin combined with spironolactone versus dapagliflozin alone in patients with heart failure, revealing significant improvements in NT-proBNP levels and safety concerns.

Evaluating the Heart Failure Risk in Type 2 Diabetes: Insights from 1.6 Million People in England
Cardiologyepidemiologyheart failure

Evaluating the Heart Failure Risk in Type 2 Diabetes: Insights from 1.6 Million People in England

By MedXY|Oct 2, 2025

This study evaluates the risk of ischaemic and non-ischaemic heart failure in over 1.6 million individuals with type 2 diabetes, highlighting critical insights for prevention strategies.

Heart Failure Risk with Pregabalin vs Gabapentin: New Evidence for Chronic Pain Management in Older Adults
CardiologyChronic Pain ManagementGabapentin

Heart Failure Risk with Pregabalin vs Gabapentin: New Evidence for Chronic Pain Management in Older Adults

By MedXY|Oct 1, 2025

New data show an increased risk of heart failure among elderly Medicare patients initiating pregabalin versus gabapentin for chronic noncancer pain, particularly in those with cardiovascular disease history.

Prev
9 / 9
1…789
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities